AGAP11
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11
Also known as: AGA11_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for AGAP11 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
550 residues, UniProt reviewed canonical sequence.
>Q8TF27|AGAP11
1 MTIISVTLEI HHHITERDAD RSLTILDEQL YSFAFSTVHI TKKRNGGGSL NNYSSSIPLT
61 PSTSQEDLYF SVPPTANTPT PICKQSMGWS NLFTSEKGSD PDKGRKALES HADTIGSGRA
121 IPIKQGMLLK RSGKWLKTWK KKYVTLCSNG VLTYYSSLGD YMKNIHKKEI DLRTSTIKVP
181 GKWPSLATSA CAPISSSKSN GLSKDMEALH MSANSDIGLG DSICFSPSIS STTSPKLNLP
241 PSPHANKKKH LKKKSTNNLK DDGLSSTAEE EEEKFMIVSV TGQTCHFKAT TYEERDAWVQ
301 AIQSQILASL QSCESSKSKS QLTSQSEAMA LQSIQNMRGN SHCVDCETQN PKWASLNLGV
361 LMCIECSGIH RSLGTRLSRV RSLELDDWPV ELRKVMSSIG NDLANSIWEG SSQGQTKPSI
421 ESTREEKERW IRSKYEHKLF LAPLPCTELS LGQHLLRATA DEDLRTAILL LAHGSREEVN
481 ETCGEGDGCT ALHLACRKGN VVLAQLLIWY GVDVMARDAH GNTALTYARQ ASSQECINVL
541 LQYGCPDECVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AGAP11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
- Arf GTPase activating protein
- Pleckstrin homology domain
- Ankyrin repeat
- PH-like domain superfamily
- Ankyrin repeat-containing domain superfamily
- ARFGAP/RecO-like zinc finger
- ArfGAP domain superfamily
- Arf-GAP with GTPase, ANK repeat and PH domain-containing protein
- PH domain
- Putative GTPase activating protein for Arf
- Ankyrin repeats (3 copies)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AGAP11 as an antibody target. Whether an autoantibody or antibody against AGAP11 could matter depends on whether native AGAP11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AGAP11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AGAP11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...